Product Information
SULFASALAZINE 500 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1991 per EA under NDC 59762500005. Its NADAC has been published 335 times since May 6, 2020.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Sulfasalazine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762500005
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SULFASALAZINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA007073FDA Approved
Before 1982
TE Code
AB
On Market Since
7/1/2003
Pharmacological Classes
Price Statistics
The NADAC for SULFASALAZINE 500 MG TABLET has been published 335 times since May 6, 2020, and over the history we have for it it has risen 22.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1991 per EA |
|---|---|
| All-time high | $0.2003 (Sep 16, 2026) |
| All-time low | $0.1285 (Apr 17, 2024) |
| 52-week high | $0.2003 |
| 52-week low | $0.1804 |
| Median price | $0.1695 |
| Average price | $0.1719 |
| Largest weekly change | +31.0% (Aug 21, 2024) |
| Weeks tracked | 335 |
| Tracking since | May 6, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sulfasalazine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminosalicylate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFASALAZINE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SULFASALAZINE 500 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.1991 per EA (NDC 59762500005), effective Sep 30, 2026.
How has the price of SULFASALAZINE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for SULFASALAZINE 500 MG TABLET has risen 22.5%. It has been tracked across 335 weekly CMS publications since May 6, 2020.
What are the highest and lowest recorded NADAC prices for SULFASALAZINE 500 MG TABLET?
Since May 6, 2020, the NADAC for SULFASALAZINE 500 MG TABLET has ranged from a low of $0.1285 (Apr 17, 2024) to a high of $0.2003 (Sep 16, 2026), with a median of $0.1695 per EA.
Are there cheaper alternatives to SULFASALAZINE 500 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SULFASALAZINE 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SULFASALAZINE 500 MG TABLET?
SULFASALAZINE 500 MG TABLET (NDC 59762500005) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.